The incidence of idiopathic nephrotic syndrome (NS) is 1· 15–16· 9 per 100 000 children,
varying by ethnicity and region. The cause remains unknown but the pathogenesis of …

Nephrotic syndrome is defined by nephrotic-range proteinuria (≥ 40 mg/m2/hour or urine
protein/creatinine ratio≥ 200 mg/mL or 3+ protein on urine dipstick), hypoalbuminaemia (< …

Background Long-term outcomes after multiple courses of rituximab among children with
frequently relapsing, steroid-dependent nephrotic syndrome (FRSDNS) are unknown …

Rituximab is an established therapy in children with idiopathic nephrotic syndrome to
sustain short-to medium-term disease remission and avoid steroid toxicities. Recent trials …

Background The majority of children who present with their first episode of nephrotic
syndrome achieve remission with corticosteroid therapy. Children who fail to respond to …

Incidence and Relapse of Idiopathic Nephrotic Syndrome: Meta-analysis | Pediatrics | American
Academy of Pediatrics Skip to Main Content Disclaimer » Advertising AAP logo Search Close …

Rituximab is an effective treatment for steroid-dependent/frequently-relapsing nephrotic
syndrome (SDFRNS) in children. However, the optimal rituximab regimen remains unknown …

Childhood nephrotic syndrome is a challenging and often persistent renal disorder, and its
incidence varies between different ethnicities and regions. Corticosteroids have been the …

Arterial hypertension (HTN) is commonly encountered by clinicians treating children with
steroid sensitive (SSNS) and steroid resistant nephrotic syndrome (SRNS). Although the …

Introduction It is unknown whether steroid sensitivity and other putative risk factors collected
at baseline can predict the disease course of idiopathic nephrotic syndrome in childhood …